Literature DB >> 23880944

Angiotensinogen gene variations and LV outflow obstruction in hypertrophic cardiomyopathy.

S Wang1, J Wang, Y Zou, J Wang, H Wang, R Hui.   

Abstract

BACKGROUND: Variations of angiotensinogen (AGT) gene have been associated with cardiac hypertrophy. We hypothesized that AGT gene polymorphism may play a modifier role in the diversity of left ventricular outflow obstruction.
METHODS: The polymorphisms of the AGT gene were genotyped in 225 patients with hypertrophic cardiomyopathy (HCM) and 243 age-and sex-matched healthy controls. The effect of the A and G alleles on the expression of the reporter gene were evaluated in vitro using dual-luciferase reporter assays.
RESULTS: Our results showed that the frequency of the A allele was higher in patients than in controls (50.2 % vs. 35.8 %, p < 0.05). Patients carrying the AA and AG genotypes had a higher proportion of left ventricular outflow obstruction (30.1 % vs. 17.0 %, p < 0.05) and heart failure (NYHA functional class III ~ IV, 35.4 % vs. 18.8 %, p < 0.05) than those carrying the GG genotype had. After adjusted for age, sex, the thickness of the interventricular septum, family history of HCM, and sudden death, the A allele conferred a 2.4-fold risk for left ventricular outflow obstruction than the GG genotype did (adjusted OR = 2.4, 95 %CI 1.2-4.8). The G allele suppressed the expression of the reporter gene significantly compared with the A allele (p < 0.05).
CONCLUSION: AGT gene variations may be genetic modifiers for the development of HCM.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23880944     DOI: 10.1007/s00059-013-3818-y

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  32 in total

1.  Advances in molecular genetics and management of hypertrophic cardiomyopathy.

Authors:  L Fananapazir
Journal:  JAMA       Date:  1999-05-12       Impact factor: 56.272

2.  Mutations profile in Chinese patients with hypertrophic cardiomyopathy.

Authors:  Lei Song; Yubao Zou; Jizheng Wang; Zhimin Wang; Yisong Zhen; Kejia Lou; Qian Zhang; Xiaojian Wang; Hu Wang; Jia Li; Rutai Hui
Journal:  Clin Chim Acta       Date:  2005-01       Impact factor: 3.786

3.  Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy.

Authors:  L Carrier; G Bonne; E Bährend; B Yu; P Richard; F Niel; B Hainque; C Cruaud; F Gary; S Labeit; J B Bouhour; O Dubourg; M Desnos; A A Hagège; R J Trent; M Komajda; M Fiszman; K Schwartz
Journal:  Circ Res       Date:  1997-03       Impact factor: 17.367

4.  Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy.

Authors:  J A Panza; R K Petrone; L Fananapazir; B J Maron
Journal:  J Am Coll Cardiol       Date:  1992-01       Impact factor: 24.094

5.  World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects.

Authors: 
Journal:  Cardiovasc Res       Date:  1997-07       Impact factor: 10.787

6.  Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.

Authors:  H Niimura; L L Bachinski; S Sangwatanaroj; H Watkins; A E Chudley; W McKenna; A Kristinsson; R Roberts; M Sole; B J Maron; J G Seidman; C E Seidman
Journal:  N Engl J Med       Date:  1998-04-30       Impact factor: 91.245

7.  A three-dimensional computational investigation of intraventricular fluid dynamics: examination into the initiation of systolic anterior motion of the mitral valve leaflets.

Authors:  A P Yoganathan; J D Lemmon; Y H Kim; R A Levine; C C Vesier
Journal:  J Biomech Eng       Date:  1995-02       Impact factor: 2.097

8.  Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.

Authors:  H Watkins; A Rosenzweig; D S Hwang; T Levi; W McKenna; C E Seidman; J G Seidman
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

9.  Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy.

Authors:  R Brugada; W Kelsey; M Lechin; G Zhao; Q T Yu; W Zoghbi; M Quinones; E Elstein; A Omran; H Rakowski; D Wigle; C C Liew; M Sole; R Roberts; A J Marian
Journal:  J Investig Med       Date:  1997-12       Impact factor: 2.895

10.  Angiotensinogen gene polymorphism in Japanese patients with hypertrophic cardiomyopathy.

Authors:  A Ishanov; H Okamoto; K Yoneya; M Watanabe; I Nakagawa; M Machida; H Onozuka; T Mikami; H Kawaguchi; A Hata; K Kondo; A Kitabatake
Journal:  Am Heart J       Date:  1997-02       Impact factor: 4.749

View more
  2 in total

Review 1.  Pediatric Cardiomyopathies.

Authors:  Teresa M Lee; Daphne T Hsu; Paul Kantor; Jeffrey A Towbin; Stephanie M Ware; Steven D Colan; Wendy K Chung; John L Jefferies; Joseph W Rossano; Chesney D Castleberry; Linda J Addonizio; Ashwin K Lal; Jacqueline M Lamour; Erin M Miller; Philip T Thrush; Jason D Czachor; Hiedy Razoky; Ashley Hill; Steven E Lipshultz
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

2.  Association between angiotensinogen M235T polymorphism and hypertrophic cardiomyopathy.

Authors:  Jia-Lu Yao; Si-Jia Sun; Ya-Feng Zhou; Lang-Biao Xu; Xiang-Jun Yang; Xiao-Dong Qian
Journal:  Int J Clin Exp Med       Date:  2015-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.